The mission of Oppenheimer’s Equity Research department is to provide thoughtful, insightful and differentiated research so that our clients can make informed investment decisions. We consist of 37 senior research analysts covering approximately 550 companies across all of the major investing sectors. Our coverage encompasses roughly 50% of the S&P 500 by market cap, and is evenly balanced among large-, mid-, and small-cap companies. As a result, Oppenheimer Equity Research continues to be an important product for our retail, institutional, and corporate clients.
Our Financial Institutions equity research is focused and in-depth. We are known as thought leaders that conduct proprietary research, deep data analysis and rigorous financial analysis.Learn more Opens in a new window
Our Healthcare research includes healthcare services, healthcare information technology (IT), medical devices, biotechnology, biopharmaceuticals, and specialty pharmaceuticals.Learn more Opens in a new window
Our research coverage includes industrial machinery and flow control, industrial multi-industry, sustainable growth and resource optimization, industrial and business services.Learn more Opens in a new window
Our Special Situations Team looks for spin-offs, post-bankruptcy equities, restructurings and management changes.
Director of Research
Associate Director of Research, Head of Research Marketing Services